33 min listen
PrEP Considerations for Transgender and Nonbinary Individuals
PrEP Considerations for Transgender and Nonbinary Individuals
ratings:
Length:
18 minutes
Released:
Jan 5, 2023
Format:
Podcast episode
Description
In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:Providing gender-affirming careIntegrating PrEP and gender careTaking a sexual history and addressing sexual healthPrEP efficacy and options for transgender individuals, including FTC/TDF, FTC/TAF, and long-acting CABThe importance of reassuring transgender individuals that data suggest there are no drug–drug interactions between gender-affirming hormone therapy and any of the PrEP options Jill Blumenthal, MD, MAS (she/hers)Associate Professor of MedicineInfectious Diseases and Global Public HealthUniversity of California, San DiegoSan Diego, California See the full program at: https://bit.ly/3WhbBvZ
Released:
Jan 5, 2023
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 4: In Part 4 of this ongoing 12-part COVID-19 series, listen to a brief update on the latest incidence trends and a concise summary of updates to the US National Institutes of Health and the Infectious Diseases Society of America recommendations for managing COVID-19, followed by answers to critical clinician questions on COVID-19 transmission, diagnosis, and management from frontline provider Vikramjit Mukherjee, MD. by CCO Infectious Disease Podcast